Clinical Trials Logo

Myopia clinical trials

View clinical trials related to Myopia.

Filter by:

NCT ID: NCT02061592 Completed - Myopia Clinical Trials

Evaluation of Etafilcon A Daily Disposable Lenses

Start date: January 2014
Phase: N/A
Study type: Interventional

To evaluate the clinical performance of daily disposable etafilcon A lenses.

NCT ID: NCT02060539 Completed - Myopia Clinical Trials

Multicenter Dispensing Study of Biofinity Lenses in Extended Range

Start date: October 2013
Phase: N/A
Study type: Interventional

To obtain subjective and objective feedback on the clinical performance of Biofinity lenses after at least two weeks daily wear in existing contact lens wearers compared with their habitual lenses.

NCT ID: NCT02060461 Completed - Myopia Clinical Trials

LASIK Flap Thickness and Visual Outcomes Using the WaveLight FS200 Femtosecond Laser

FS200
Start date: August 2012
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the visual outcome, accuracy, predictability and complications of LASIK flap creation using the Alcon Wavelight FS200 Femtosecond laser and compare these results to those obtained using current IntraLase FS60 Femtosecond laser. The primary outcome to be evaluated is the flap thickness accuracy.

NCT ID: NCT02055378 Completed - Myopia Clinical Trials

the Effect of Low-Concentration Atropine Combined With Auricular Acupoint Stimulation in Myopia Control

Start date: January 2011
Phase: N/A
Study type: Interventional

To compare the effect of myopia control between patients treated with low-concentration atropine eye drops combined with auricular acupoint stimulation and those treated with atropine alone.

NCT ID: NCT02034006 Completed - Clinical trials for Choroidal Neovascularization Secondary to Pathologic Myopia

A Study of the Criteria Establishing the Need for Re-treatment With Ranibizumab Upon Relapse in Patients With Visual Impairment Due to Choroidal Neovascularization Secondary to Pathologic Myopia.

OLIMPIC
Start date: June 10, 2014
Phase: Phase 3
Study type: Interventional

The primary objective of the study was to investigate current criteria driving re-treatment in patients affected by Choroidal Neovascularization (CNV) secondary to Pathologic Myopia (PM) and experiencing a relapse of the disease after the first administration of ranibizumab.

NCT ID: NCT02024698 Completed - Myopia Clinical Trials

Multi-center Clinical Evaluation of PC 1-Day vs 1-Day Acuvue Moist

Start date: January 2014
Phase: N/A
Study type: Interventional

The objective of this study is to compare the clinical performance of ProClear 1-Day versus 1-Day Acuvue Moist each for one week of daily disposable wear.

NCT ID: NCT01996787 Completed - Myopia Clinical Trials

Clinical Study of Visibility Tinted Clariti Contact Lens

Start date: June 2013
Phase: N/A
Study type: Interventional

The purpose of this study was to investigate the safety and efficacy of the Sauflon Clariti Monthly silicone hydrogel contact lenses with handling tint (Sauflon Pharmaceuticals Limited) by comparison with Air Optix Aqua silicone hydrogel lenses (Alcon Inc.) Subjects used OptiFree Replenish solution (Alcon Lboratories Inc.) for daily lens maintenance, care and storage.

NCT ID: NCT01995435 Completed - Eye Strain, Clinical Trials

Refraction Determination Analysis

Start date: February 2015
Phase: N/A
Study type: Interventional

Correlating the accuracy of a refraction done over telemedicine to that of a standard refraction, with a study hypothesis that the results will be equivalent.

NCT ID: NCT01988415 Completed - Myopia Clinical Trials

New Treatment Algorithm to Reduce Spherical Aberration After LASIK Correction for Myopia

Start date: November 2013
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to demonstrate that treatments generated by an investigational algorithm reduces spherical aberration compared to currently available iDesign treatments.

NCT ID: NCT01968486 Completed - Clinical trials for Myopia, Degenerative

Reduced-fluence Verteporfin Photodynamic Therapy Plus Ranibizumab for Choroidal Neovascularization in Pathologic Myopia

Start date: June 2012
Phase: Phase 1
Study type: Interventional

To demonstrate the efficacy of ranibizumab in combination with reduced-fluence verteporfin photodynamic therapy (RF-PDT) in patients with subfoveal choroidal neovascularization secondary to pathologic myopia (PM).